Active, not recruitingPHASE1, PHASE2NCT04693598

Gene Transfer Clinical Trial for Krabbe Disease

Studying Krabbe disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Forge Biologics, Inc
Intervention: FBX-101(biological)
Enrollment: 6 enrolled
Eligibility: All sexes
Timeline: 2021 – 2026

Study locations (1)

University of Michigan Hospitals - Michigan Medicine, Ann Arbor, Michigan, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04693598 on ClinicalTrials.gov

Other trials for Krabbe disease

Additional recruiting or active studies for the same condition.

RECRUITINGNCT02993796
Krabbe Disease Global Patient Registry
State University of New York at Buffalo
ACTIVE NOT RECRUITINGNCT00787865
Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease
University of Pittsburgh

See all trials for Krabbe disease →

← Back to all trials